EDGAR Filing Documents for 0001193125-09-130651

Form 8-K - Current report:

SEC Accession No. 0001193125-09-130651

Filing Date

2009-06-15

Accepted

2009-06-15 10:27:47

Documents

Period of Report

2009-06-10

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d8k.htm	8-K	21255
2	AMENDED AND RESTATED EXECUTIVE CHANGE-IN-CONTROL PLAN	dex101.htm	EX-10.1	26425
3	FORM OF RESTRICTED STOCK AGREEMENT	dex102.htm	EX-10.2	19784
4	FORM OF STOCK OPTION AGREEMENT	dex103.htm	EX-10.3	24405
5	PRESS RELEASE	dex991.htm	EX-99.1	6988
	Complete submission text file	0001193125-09-130651.txt		100486

Mailing Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010

Business Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010 212-994-8200

ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)